Search
for
Sort by
Research 241–270 of 520
- Early prediction of alopecia areata using machine learning modeling of neuro stress immune signatures from multi datasets
- Longitudinal clinical course, treatment outcomes, and relapse patterns in alopecia areata: a prospective cohort study
- MANAGEMENT OF INDRALUPTA- A CASE REPORT
- Impacto del desequilibrio del microbioma del cuero cabelludo en la severidad de la alopecia areata, marcadores inflamatorios y cambios post-tratamiento
- Traditional and Integrative Approaches to the Treatment of Alopecia
- Hashimoto Thyroiditis - A Comprehensive Review
- THE PATHOGENESIS OF ALOPECIA AREATA
- Treatments for alopecia areata: a network meta-analysis
- A Review on Nanoparticle Based Herbal Remedies for the Management of Alopecia
- Immunohistochemical assessment of SOX10 and its relation to the immune cellular infiltrate in alopecia areata follicles
- The Use of 308-nm Excimer Laser Therapy in Alopecia Areata and Primary Cicatricial Alopecia: A Systematic Review
- Treatment of alopecia totalis/universalis/focalis with vitamin D and analogs: Three case reports and a literature review
- 186 Mechanistic insights into Ritlecitinib-mediated immunomodulation in Alopecia Areata
- Assessment of vitamin D levels in patients with alopecia areata: a case-control study in a Tertiary Care Hospital in North India
- Gene Expression of CD70 and CD27 Is Increased in Alopecia Areata Lesions and Associated with Disease Severity and Activity
- Immune therapies for alopecia areata: evidence and new perspectives
- Fractional carbon dioxide laser alone and as an assisted drug delivery for treatment of alopecia areata: a clinical, dermoscopic and immunohistochemical study
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Tru9I Variant as a Novel Genetic Marker for Vitamin D Deficiency in Alopecia Areata
- Reversal of alopecia areata, osteoporosis follow treatment with activation of Tgr5 in mice
- Efficacy and safety of ritlecitinib in Asian patients with alopecia areata: A subgroup analysis of the ALLEGRO phase 2b/3 trial
- Elevated serum heat shock protein-70 and interleukin-15: prognostic biomarkers correlating with clinical severity and diagnostic efficacy in active alopecia areata
- AIRE Deficiency Leads to the Development of Alopecia Areata‒Like Lesions in Mice
- Prevalence, comorbidities, and treatment patterns of Japanese patients with alopecia areata: A descriptive study using Japan medical data center claims database
- Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience
- Selective Expression of Chemokine Monokine Induced by Interferon-γ in Alopecia Areata
- Vaccines, adjuvants and autoimmunity
- Coexistence of dermatomyositis and alopecia areata: Insight into pathogenesis
- Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study
- Patterns of clinical response in patients with alopecia areata treated with ritlecitinib in the ALLEGRO clinical development programme